Earnings
Elevance Keeps Its $29.00 Adjusted Earnings Floor And Holds Its Medical-Cost Forecast
Approximately $7.00 per share in unfavorable items separates the insurer's adjusted outlook from its standard-accounting forecast.
Elevance Health (ELV) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Earnings
Approximately $7.00 per share in unfavorable items separates the insurer's adjusted outlook from its standard-accounting forecast.
SEC Filings
The 10-Q shows operating gain slipped to $1,269 million while a $669 million dispute-resolution accrual was recorded.
Earnings
Analysts pressed Elevance on Medicaid rates and margins after it lifted 2026 guidance to at least $29 a share.
Earnings
The insurer's benefit expense ratio improved to 90.6%, and results included a net non-operating benefit of $1.85 per share.